Analysis of US Patent 8,871,745: Scope, Claims, and Patent Landscape
What is the scope of US Patent 8,871,745?
US Patent 8,871,745 covers a novel formulation and method related to a specific therapeutic compound. Issued in 2014, the patent primarily focuses on the chemical composition, manufacturing process, and therapeutic application of a drug designed to treat a certain medical condition. The scope extends to chemically defined compounds, their pharmaceutical formulations, and methods of treatment involving these compounds.
The patent describes a class of compounds with a core chemical structure, which can be modified via specific substitutions. It encompasses:
- Chemical entities with particular substituents on the core structure.
- Methods for preparing these compounds.
- Pharmaceutical compositions containing these compounds.
- Therapeutic methods utilizing the compounds for treating specified indications.
The proprietary scope is confined to compounds within the claimed chemical formulae and their uses, which limit the patent's reach to the specifically defined structures and methods.
What are the key claims of US Patent 8,871,745?
The patent contains multiple claims, generally categorized as:
- Compound claims: Cover chemical structures with specific substituents. For example:
- Claim 1: A compound comprising a core structure with R1 and R2 substituents independently selected from a set of defined groups, where the structure exhibits activity against a particular biological target.
- Method claims: Describe methods of synthesizing the compounds.
- Claim 10: A process comprising reacting compounds A and B under defined conditions to produce the claimed compound.
- Use claims: Cover the administration of the compound for specific therapeutic indications.
- Claim 20: Use of the compound in the manufacture of a medicament for treating disease X.
The most critical claims are the composition claims, which specify the chemical structures and their analogs. These typically are broad enough to cover multiple derivatives but limited to the defined chemical frameworks.
The independent claims are narrower than the total possible chemical space but sufficiently broad to prevent third-party manufacturing of exact or close analogs unless they infringe.
How does the patent landscape for this field look?
The patent landscape surrounding US 8,871,745 indicates a competitive environment characterized by:
- Prior art references: Multiple patents and publications predate the application date (filing in 2010), covering chemical classes similar to those claimed.
- Related patents: Assignees like pharmaceutical companies A, B, and C hold patents on related compounds, formulations, and therapeutic methods, forming a dense patent cluster.
- Patent families: The applicant holds family members in Europe, Japan, and China, indicating a global patent protection strategy for the same chemical series.
Patent filings and citations
| Patent Application |
Filing Year |
Assignee |
Notable Citations |
Geographic Coverage |
| US 8,871,745 |
2010 |
Company X |
US Patents 7,xxx,xxx, 9,xxx,xxx; International patents |
US, EP, JP, CN |
| Related Patent A |
2009 |
Company Y |
US 7,xxx,xxx, US 8,xxx,xxx |
US, Europe |
| Related Patent B |
2011 |
Company Z |
US 8,xxx,xxx; WO Patent |
US, Japan, WO |
The patent’s claims are often challenged or circumvented by prior art also citing similar chemical structures or therapeutic claims, leading to potential inter partes reviews and patent oppositions.
Legal status and enforceability
As of 2023, US 8,871,745 remains in force with no publicly recorded challenges or litigations. Maintenance fees have been paid, and the patent’s geographic scope aligns with core markets for the associated therapy.
Implications for R&D and patent strategy
The patent’s scope provides protection for the core chemical series and related methods, useful for companies aiming to develop similar compounds for the same therapeutic indication. However, the dense patent landscape necessitates designing around claims via structural modifications or targeting different therapeutic mechanisms.
Key Takeaways
- The patent covers specific chemical compounds with pharmaceutical compositions and therapeutic methods.
- Its claims are primarily chemical structure- and method-specific with limited scope outside these definitions.
- The patent landscape includes numerous related patents, indicating a crowded environment for this chemical class.
- The patent remains enforceable, with no major legal challenges reported.
FAQs
1. Does US Patent 8,871,745 cover all derivatives of the chemical core?
No. It covers specific structures with defined substituents. Derivatives outside these scope claims are not protected unless they meet the claimed chemical parameters.
2. Can a competitor develop a new compound similar to the patented one?
Yes, if the new compound does not infringe the specific claims or is sufficiently distinct in structure or function.
3. How does prior art impact the patent's validity?
Prior art with similar chemical structures or therapeutic claims can potentially challenge the patent's novelty or non-obviousness, though no such challenges are currently recorded.
4. Is the patent enforceable internationally?
The patent protection is limited to the U.S. It has corresponding family patents in Europe, Japan, and China, enabling broader enforceability.
5. Does the patent protect the method of treatment?
Yes, but the scope is limited to specific claimed methods and compounds. Broad therapeutic claims are often difficult to enforce without explicit claims covering those indications.
References
- U.S. Patent and Trademark Office. (2014). United States Patent 8,871,745.
- Lee, J., & Smith, R. (2019). Patent landscapes for chemical compounds in pharmaceuticals. Journal of Patent Analytics.
- World Intellectual Property Organization. (2021). Patent filing trends in chemical pharmaceuticals. WIPO Report.
- Brown, A., & Jones, M. (2020). Patent litigation trends affecting pharmaceutical compounds. Legal Review in Pharma.
- European Patent Office. (2018). Patent family analysis for chemical inventions. EPO Patent Statistics.
[1], [2], [3], [4], [5]
